MedPath

Survey on the impact of hypnotic usage in patients with chronic insomnia

Not Applicable
Conditions
insomnia
Registration Number
JPRN-UMIN000016157
Lead Sponsor
europsychiatric Research Institute
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
300
Inclusion Criteria

Not provided

Exclusion Criteria

1) unable to read the description document of the present study, those who cannot understand the purpose of study 2) unable to answer by oneself or no consent capacity for his or her mental and physical symptoms 3) to be judged inappropriate/unsuitable to this research by attending physician

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
hypnotic withdrawal scale, QOL-I (Quality of Life Scale for Insomnia)
Secondary Outcome Measures
NameTimeMethod
Athens Insomnia Scale, Insomnia Severity Index, HyperArousal Scale, modified version of Clinical Global Impression (entire life, dependency, withdrawal), Ford Insomnia Response to Stress Test, Sheehan Disability Scale, Short-Form 8-item health Survey, Benzodiazepine Dependence Self-Report Questionnaire, Clinical Institute Withdrawal Assessment for Benzodiazepines
© Copyright 2025. All Rights Reserved by MedPath